On Thursday, New Residential Investment Corp (NYSE:NRZ)’s shares declined -0.41% to $14.54.
NRG Energy, Inc. ( NRG ) stated second quarter Adjusted EBITDA of $729 million 1 , with $338 million from NRG Business and NRG Renew combined 5 , $204 million from NRG Home Retail, and $187 million from NRG Yield. Year-to-date adjusted cash flow from operations totaled $678 million. Net loss for the first six months of 2015 was $145 million, or $0.43 per diluted common share contrast to a net loss of $147 million, or $0.48 per diluted common share for the first six months of 2014.
NRG Business: Second quarter Adjusted EBITDA was $285 million; $16 million lower than in the second quarter 2014 primarily driven by:
- East Region: $11 million lower due to lower energy margins caused by milder weather and lower capacity revenues due to lower base residual auction prices and less capacity following plant deactivations, partially offset by lower operating costs due to fewer outages and reduced run time
- West Region: $26 million lower due to reduced pricing and a decline in contracted volumes from certain capacity contracts counting the retirement of Coolwater
- Gulf Coast Region: $27 million enhance due to higher realized energy margins, partially offset by raised outage costs during planned outages for fuel conversion and back-end control installations.
New Residential Investment Corp., a real estate investment trust (REIT), focuses on investing in and managing residential mortgage related assets. It operates through Servicing Related Assets, Residential Securities and Loans, and Other Investments segments. The company invests in excess mortgage servicing rights (MSRs) on residential mortgage loans; and in servicer advances, counting the basic fee component of the related MSRs.
Synthetic Biologics Inc (NYSEMKT:SYN)’s shares dropped -3.78% to $2.43.
Synthetic Biologics, Inc. (SYN), a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, stated financial results for the three and six months ended June 30, 2015, and offered an operational update.
Clinical Program Progress
Prevention of C. difficile infection and AAD – SYN-004:
- Dosed first participant in second Phase 2a clinical trial to evaluate the GI antibiotic-degrading effects and safety of SYN-004 in the presence of the proton pump inhibitor (PPI), esomeprazole
- Stated data from first four of 12 predictable participants in first Phase 2a open-label clinical trial; data showed that SYN-004 degraded IV ceftriaxone in the chyme of the four healthy participants with functioning ileostomies without affecting ceftriaxone in the bloodstream
- Expect topline data from first Phase 2a clinical trial (3Q 2015)
- Plan to initiate a Phase 2b proof-of-concept clinical trial (3Q 2015); anticipate enrolling about 370 patients at up to 75 global sites; anticipate interim analysis of blinded data (2H 2015)
- Expect topline data from second Phase 2a clinical trial (2H 2015)
Synthetics Biologics, Inc., a clinical-stage biotechnology company, develops pathogen-specific therapies for serious infections and diseases with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV) antibiotics for the prevention of C. difficile infection; an oral statin treatment to reduce the impact of methane producing organisms on irritable bowel syndrome with constipation (IBS-C); and a monoclonal antibody combination for the treatment of Pertussis.
At the end of Thursday’s trade, STMicroelectronics NV (ADR)(NYSE:STM)‘s shares dipped -2.37% to $7.40.
STMicroelectronics (STM), a global semiconductor leader serving customers across the spectrum of electronics applications, recently declared the STiD325 (codenamed Barcelona), its DOCSIS[1] 3.1 chipset for Broadband CPE[2] Cable Modems, embedded Media Terminal Adapters (eMTAs), and Gateways, in addition to for Video Gateways when associated to set-top-box chipsets. It is being demonstrated at CableLabs Summer Conference, August 2-5, 2015 in Keystone, Colorado, USA.
DOCSIS 3.1 has been engineered by CableLabs® to unleash the multi-gigabit data era on existing Hybrid Fiber-Coax (HFC) netoperates through improved spectral efficiency using OFDM[3] multi-carrier modulation combined with low-density parity-check-based Forward Error Correction.
STMicroelectronics N.V. designs, develops, manufactures, and markets various semiconductor integrated circuits and discrete devices worldwide. The company offers a range of semiconductor products, counting discrete and standard commodity components, application-specific integrated circuits, full-custom devices and semi-custom devices, micro-electro-mechanical systems, microcontrollers, sensors, digital consumer products, imaging products, memory products, media application processors, and application-specific standard products for analog, digital, and mixed-signal applications, in addition to silicon chips and smartcards.
Urban Outfitters, Inc. (NASDAQ:URBN), ended its Thursday’s trading session with -0.71% loss, and closed at $32.34.
Urban Outfitters, Inc. (URBN) a leading lifestyle specialty retail company operating under the Anthropologie, Bhldn, Free People, Terrain and Urban Outfitters brands, declared net income of $33 million for the three months ended April 30, 2015. Earnings per diluted share were $0.25 for the three months ended April 30, 2015.
Total Company net sales for the first quarter of fiscal 2016 raised 8% over the same quarter last year to a record $739 million. Comparable Retail segment net sales, which comprise our comparable direct-to-consumer channel, raised 4%. Comparable Retail segment net sales raised 17% at Free People, 5% at Urban Outfitters and 1% at the Anthropologie Group. Wholesale segment net sales rose 18%.
As of April 30, 2015, total inventories raised by $49 million, or 14%, on a year-over-year basis. The growth in total inventories is primarily related to an enhance in comparable Retail segment inventories and the acquisition of inventory to stock new and non-comparable stores. Comparable Retail segment inventories raised 8% at cost while decreasing 5% in units.
For the three months ended April 30, 2015, selling, general and administrative expenses, expressed as a percentage of net sales, raised by 13 basis points when contrast to the prior year period. The enhance was primarily due to raised marketing and technology expenses that were used to drive higher direct-to-consumer traffic.
The Company`s effective tax rate for the first quarter of fiscal 2016 was 35.6% contrast to 37.0% in the prior year period. The tax rate variance is due to state tax adjustments in the prior year quarter.
Urban Outfitters, Inc., a lifestyle specialty retail company, engages in the retail and wholesale of general consumer products. The company operates in two segments, Retail and Wholesale. It serves its customers directly through retail stores, Websites, mobile applications, catalogs, and customer contact centers. The company operates retail stores under the Urban Outfitters, Anthropologie, Free People, Terrain, and Bhldn brands.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
